NSUN5 methylation-mediated overexpression of NQO1 can also constitute a therapeutic opportunity in these gliomas, because they become more sensitive to ROS-induced death upon the use NQO1-bioactivatable molecules [19, 27, 30]. Here, NSUN5 is linked to central nervous system cancer.